BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15509492)

  • 1. Effectiveness of radiochemotherapy on lymph node metastases in patients with stage IV oropharyngeal cancer.
    Sapundzhiev NR; Barth PJ; Vacha P; Dünne AA; Moll R; Engenhart-Cabillic R; Werner JA
    Oral Oncol; 2004 Nov; 40(10):1007-16. PubMed ID: 15509492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
    Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Level V lymph node dissection in oral and oropharyngeal carcinoma patients with clinically node-positive neck: is it absolutely necessary?
    Lim YC; Koo BS; Lee JS; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1232-5. PubMed ID: 16826066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative paclitaxel/carboplatin radiochemotherapy for stage III/IV resectable oral and oropharyngeal cancer: seven-year follow-up of a phase II trial.
    Eckardt A; Sinikovic B; Hofele C; Bremer M; Reuter C
    Oncology; 2007; 73(3-4):198-203. PubMed ID: 18424883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Level IIb lymph node metastasis in elective neck dissection of oropharyngeal squamous cell carcinoma.
    Lee SY; Lim YC; Song MH; Lee JS; Koo BS; Choi EC
    Oral Oncol; 2006 Nov; 42(10):1017-21. PubMed ID: 16757201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative radiochemotherapy and radical resection for stages II-IV oral and oropharyngeal cancer: outcome of 222 patients.
    Klug C; Wutzl A; Kermer C; Voracek M; Kornek G; Selzer E; Glaser C; Poeschl PW; Millesi W; Ewers R
    Int J Oral Maxillofac Surg; 2005 Mar; 34(2):143-8. PubMed ID: 15695042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients.
    Eich HT; Löschcke M; Scheer M; Kocher M; Bongartz R; Wacker S; Zöller JE; Müller RP
    Strahlenther Onkol; 2008 Jan; 184(1):23-9. PubMed ID: 18188519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of metastatic lymph nodes in oropharyngeal carcinoma and its implications for the elective treatment of the neck.
    Vartanian JG; Pontes E; Agra IM; Campos OD; Gonçalves-Filho J; Carvalho AL; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):729-32. PubMed ID: 12874073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of contralateral N0 neck in pyriform sinus carcinoma.
    Koo BS; Lim YC; Lee JS; Kim YH; Kim SH; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1268-72. PubMed ID: 16826073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is dissection of level IV absolutely necessary in elective lateral neck dissection for clinically N0 laryngeal carcinoma?
    Lim YC; Choi EC; Lee JS; Koo BS; Song MH; Shin HA
    Oral Oncol; 2006 Jan; 42(1):102-7. PubMed ID: 16143563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral neck node metastasis: a predictor of isolated distant metastasis in patients with oral and oropharyngeal squamous cell carcinoma after primary curative surgery.
    Lim YC; Koo BS; Choi EC
    Laryngoscope; 2007 Sep; 117(9):1576-80. PubMed ID: 17667136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical node metastases in oropharyngeal squamous cell carcinoma: prospective analysis of prevalence and distribution.
    Jose J; Coatesworth AP; Johnston C; MacLennan K
    J Laryngol Otol; 2002 Nov; 116(11):925-8. PubMed ID: 12487673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation.
    Robbins KT; Doweck I; Samant S; Vieira F
    Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):965-9. PubMed ID: 16301367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic validation of the sentinel node concept in oral and oropharyngeal squamous cell carcinoma.
    Nieuwenhuis EJ; van der Waal I; Leemans CR; Kummer A; Pijpers R; Castelijns JA; Brakenhoff RH; Snow GB
    Head Neck; 2005 Feb; 27(2):150-8. PubMed ID: 15627261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective neck dissection for N0 and N1 oral cavity and oropharyngeal cancer: are skip metastases a real danger?
    Lodder WL; Sewnaik A; den Bakker MA; Meeuwis CA; Kerrebijn JD
    Clin Otolaryngol; 2008 Oct; 33(5):450-7. PubMed ID: 18983378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.